| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | $1,958,354 | -10,846 | -0.17% | $180.56 | 6,242,524 | 25 Jun 2021 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | $1,489,959 | -8,225 | -0.13% | $181.15 | 6,234,299 | 28 Jun 2021 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $181.505. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $182.265. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |